Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025

GlobeNewswireDec 17 21:05

Express News | Scienture, LLC, a Wholly Owned Subsidiary of Scienture Holdings, Inc. (Nasdaq: Scnx) Announces Issuance of a New Patent Covering Its First Product Scn-102 (Losartan Potassium Oral Suspension, 10Mg/Ml) Through 2041

BreakingsDec 10 21:05

Express News | Scienture Holdings Inc Files for Resale of up to 4.3 Mln Shares of Common Stock - SEC Filing

BreakingsDec 4 23:42

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaDec 3 05:05

Scienture Holdings Secures Funding for Strategic Growth

TipRanksNov 27 05:35

Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry Into $50 Million Equity Line of Credit Agreement

GlobeNewswireNov 27 05:05